Rami Levin
CIK: 0002102719
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)1 (50.0%)
Derivative conversions
Awards (A)1 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CNSP
CNS Pharmaceuticals, Inc.
Officer
Discretionary Trading P&L
Holdings
About Levin Rami
Levin Rami (SEC CIK 0002102719) files insider reports with the SEC as CEO and President of CNS Pharmaceuticals, Inc. (CNSP).
Signal8 holds 3 ownership filings by Levin Rami (1 Form 3, 2 Form 4), filed between Jan 2, 2026 and Aug 18, 2026. Those filings report 2 transactions, from Jan 1, 2026 to Aug 14, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Levin Rami's filings is in HOUSTON, TX.
Recent filings by Levin Rami
Other insiders filing for CNS Pharmaceuticals, Inc. (CNSP)
- Fisher Michal, Director
- Charles Faith L., Director
- Faulkner Eric, Chief Technology Officer
- O'Loughlin Steve, Chief Financial Officer
- Keyes Jeffry R., Director
- Cockroft Bettina M., Director